CTBC Venture Capital
Overview
CTBC Venture Capital is the corporate venture capital arm of CTBC Financial Holding that invests in information technology, communications, biotechnology, healthcare, cultural/creative, and alternative energy industries.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EnCharge AI | Feb 2025 | Series B | Co-investor |
| iCHEF | Feb 2016 | Series A | Co-investor |
| PackAge+ | Mar 2023 | Pre Seed | Co-investor |
| WCC Biomedical | Jun 2023 | Series B | Co-investor |
| Libo Pharma Corp. | Jul 2025 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CTBC Venture Capital based?
CTBC Venture Capital is headquartered in Taipei, Taiwan.
When was CTBC Venture Capital founded?
CTBC Venture Capital was founded in 2003.
How many portfolio companies does CTBC Venture Capital have?
CTBC Venture Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in CTBC Venture Capital's portfolio?
Portfolio companies visible on Caplight include EnCharge AI, iCHEF, PackAge+, WCC Biomedical, Libo Pharma Corp..
What was CTBC Venture Capital's most recent investment shown here?
CTBC Venture Capital's most recent investment in this portfolio sample was in Libo Pharma Corp. in 2025.
What sectors does CTBC Venture Capital focus on?
CTBC Venture Capital focuses on Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Energy & Sustainability, FinTech, FinTech, Mobility, Transportation & Logistics, Enterprise Software, Crypto & Web3, Frontier & Industrial Tech, Consumer & Commerce, Consumer & Commerce.
What company stages does CTBC Venture Capital focus on?
CTBC Venture Capital typically invests at the Early stage.